HOCl-producing Electrochemical Bandage is Active in Murine Polymicrobial Wound Infection

This is the authors' abstract. We don't add key points for this paper.

Wound infections, exacerbated by the prevalence of antibiotic-resistant bacterial pathogens, necessitate innovative antimicrobial approaches. Polymicrobial infections, often involving Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus (MRSA), present formidable challenges due to biofilm formation and antibiotic resistance. Hypochlorous acid (HOCl), a potent antimicrobial agent produced naturally by the immune system, holds promise as an alternative therapy. An electrochemical bandage (e-bandage) that generates HOCl in situ was evaluated for treatment of murine wound biofilm infections containing both MRSA and P. aeruginosa with “difficult-to-treat” resistance. Previously, the HOCl-producing e-bandage was shown to reduce wound biofilms containing P. aeruginosa alone. Compared to non-polarized e-bandage (no HOCl production) and Tegaderm only controls, the polarized e-bandages reduced bacterial loads in wounds infected with MRSA plus P. aeruginosa (MRSA: vs Tegaderm only – 1.4 log 10 CFU/g, p = 0.0015, vs. non-polarized – 1.1 log 10 CFU/g, p = 0.026. P. aeruginosa : vs Tegaderm only – 1.6 log 10 CFU/g, p = 0.0015, vs non-polarized – 1.6 log 10 CFU/g, p = 0.0032), and MRSA alone (vs Tegaderm only – 1.3 log 10 CFU/g, p = 0.0048, vs. non-polarized – 1.1 log 10 CFU/g, p = 0.0048), without compromising wound healing or causing tissue toxicity. Addition of systemic antibiotics did not enhance the antimicrobial efficacy of e-bandages, highlighting their potential as standalone therapies. This study provides additional evidence for the HOCl-producing e-bandage as a novel antimicrobial strategy for managing wound infections, including in the context of antibiotic resistance and polymicrobial infections.